Found 284 matching trials
Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD PHASE2 To evaluate the safety of 3 regimens of short-term, low-dose systemic IMT a...
Show More Location
Wills Eye Institute
Learn More & Join Trial
Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen PHASE3 The purpose of this study is to demonstrate non-inferiority of an advagraf ...
Show More Location
Universitätsklinikum Carl Gustav Carus
Learn More & Join Trial
Immunosuppressant Regimens for Living Fetuses Study NA Undifferentiated connective tissue diseases (UCTD) are known to increase th...
Show More Learn More & Join Trial
Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung Disease N/A Idiopathic inflammatory myopathies (IIM) are a group of autoimmune conditio...
Show More Location
Singapore General Hospital
Learn More & Join Trial
Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus PHASE4 Following a transplant for hepatitis C cirrhosis, the infection comes back ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis PHASE1 One of the possible options for the treatment of MS at present is a high-do...
Show More Location
First Pavlov State Medical University of St. Petersburg
Learn More & Join Trial
Efficacy Regarding Renal Function of Everolimus in Combination With Specific Standard Immunosuppressive Regimen Lung Transplant Recipients PHASE3 This trial evaluated the efficacy of an everolimus-based quadruple low immu...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
COVID Protection After Transplant-Immunosuppression Reduction PHASE2 This study will enroll individuals who have:
* Completed primary series of...
Show More Location
University of California, San Diego
Learn More & Join Trial
Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years PHASE2 Outcomes for adult patients with Severe Aplastic Anemia (SAA) aged more tha...
Show More Location
Saint Louis hospital
Learn More & Join Trial
A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAF PHASE4 The purpose of this study is to evaluate the efficacy of tacrolimus modifie...
Show More Location
Multiple Locations
Learn More & Join Trial